TrialCOPD2013

Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study.

Jutta Beier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.